Is your organization struggling to navigate the complexities of 340B transparency and the constant wave of legislative updates? Join us to learn how to stay ahead of new regulations and ensure compliance with ease. Speakers: Deborah Outlaw, Founder and Principal of The Outlaw Group Mark Slykhouse, VP Product Management - MSP Portfolio at The Craneware Group

With 20+ contract pharmacy access bills expected to pass this year, manufacturer restrictions may soon be a thing of the past. But the legal side is just the first step. In this webinar, we cover 5 essential changes you must make to the way your TPA processes 340B claims in order to restore program benefits across your pharmacy network. Key Questions We Answer: - Does 340B pricing automatically come back? - Will manufacturers comply—or will there be pushback? - What operational changes do you need to make NOW? - How far back can you go when reprocessing claims? - What role can YOU play in ensuring compliance? What You’ll Learn: - The state-by-state landscape of new 340B access laws - The 5 crucial steps to adjust your operations & restore pricing - How to navigate reprocessing rules & potential challenges - What’s next for advocacy & legal enforcement 340B is evolving FAST—if you’re not prepared, you’re at risk. Watch now and stay ahead of the game!

Join us on April 22nd at 1:00 p.m. EST for the third installment in Clearinghouse series, Neutral 340B Clearinghouse: Now Live! Special guest speakers David Christian, Pharmacy Director of Central Virginia Health Services, and Elena Nicolella, President of Rhode Island Health Center Association will join us for an exciting conversation highlighting why CVHS and RIHCA have already implemented RxParadigm's Tungsten+PLUS™ Neutral 340B Clearinghouse solution. We will also focus on how the neutral Clearinghouse addresses the intersection between CMS’ Medicare Transaction Facilitator and 340B programs. Be sure to sign up today!

Join us for an exclusive webinar where we break down AI beyond the buzzword and explore its real-world applications in the 340B space. Ted Slafsky, a national leader and expert in 340B policy, will set the stage with the latest updates shaping the program while Ali Farzad, CompassRx's CEO, will share how AI technologies can be used to help covered entities face the growing challenges in the space.